Hope for severe asthma: study tests if biologics can heal lungs
NCT ID NCT07174713
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether biologic therapy can reverse long-term lung damage in adults with severe asthma. Researchers will follow 150 patients and 50 healthy volunteers for two years, using advanced imaging and lung function tests. The goal is to see if treatment leads to 'clinical remission' and if the lungs can heal at the airway and blood vessel level.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Biologic therapy (a type of drug that blocks specific inflammation pathways in asthma)
What this could lead to
If successful, this could show that biologic therapy not only controls symptoms but may reverse some lung damage in adults with severe asthma, pointing toward a deeper remission.
What could go wrong
This is an observational study, not a treatment trial, so it won't prove the therapy works. Results may vary by age and asthma duration, and the study is still recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Robarts Research Institute; The University of Western Ontario
London, Ontario, N6A 5B7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••